ABSTRACT Preliminary reports have documented the utility of balloon aortic valvuloplasty as a palliative treatment for high-risk patients with critical aortic stenosis, but the effect of this procedure on cardiac performance has not been studied in detail. Accordingly, 32 patients (mean age 79 years) with long-standing, calcific aortic stenosis were treated at the time of cardiac catheterization with balloon dilatation of the aortic valve, and serial changes in left ventricular and valvular function were followed before and after valvuloplasty by radionuclide ventriculography, determination of systolic time intervals, and Doppler echocardiography. Prevalvuloplasty examination revealed heavily calcified aortic valves in all patients, a mean peak-to-peak aortic valve gradient of 77 + 27 mm Hg, a mean Fick cardiac output of 4.6 ± 1.4 liters/min, and a mean calculated aortic valve area of 0.6 + 0.2 cm2. Subsequent balloon dilatation with 12 to 23 mm valvuloplasty balloons resulted in a fall in aortic valve gradient to 39 + 15 mm Hg, an increase in cardiac output to 5.2 + 1.8 liters/min, and an increase in calculated aortic valve area to 0.9 ± 0.3 cm2. Individual hemodynamic responses varied considerably, with some patients showing major increases in valve area, while others demonstrated only small increases. In no case was balloon dilatation accompanied by evidence of embolic phenomena. Supravalvular aortography obtained in 13 patients demonstrated no or a mild (less than or equal to 1 +) increase in aortic insufficiency. Serial radionuclide ventriculography in patients with a depressed left ventricular ejection fraction (i.e., that c55%) revealed a small increase in ejection fraction from 40 + 13% to 46 ± 12% (p < .03). In addition, for the study group as a whole there was a decrease in left ventricular end-diastolic volume index (113 + 38 to 101 + 37 ml/m2, p < .003), a fall in strokevolume ratio (1.49 ± 0.44 to 1.35 + 0.33, p < .04), and no immediate change in left ventricular peak filling rate (2.05 + 0.77 to 2.21 ± 0.65 end-diastolic counts/sec, p = NS). Serial M mode echocardiography and phonocardiography showed an increase in aortic valve excursion (0.5 ± 0.2 to 0.8 ± 0.2 cm, p < .001), a decrease in time to one-half carotid upstroke (80 ± 30 to 60 ± 10 msec, p < .001), and a small decrease in left ventricular ejection time (0.44 ± 0.03 to 0.42 ± 0.02 sec, p < .001). We conclude that percutaneous aortic valvuloplasty in adult patients with calcific aortic stenosis may result in improved aortic valve and left ventricular systolic function. Individual responses to balloon dilatation may vary considerably, with some patients demonstrating dramatic improvement in valvular and ventricular function, while others show little change.
be successful in treating high-risk patients with calcific aortic stenosis. Although preliminary reports on aortic valvuloplasty have been favorable, the effect of this procedure on left ventricular and aortic valve function has not been studied in detail. Accordingly, the purpose of the present study was to assess the effect of balloon dilatation of the aortic valve on cardiac performance in a group of adult patients with long-standing, calcific aortic stenosis.
Methods
Study group. Balloon aortic valvuloplasty was attempted at the time of cardiac catheterization in a total of 33 patients (13 men and 20 women) with a mean age of 79 years (range 35 to 93). All patients were symptomatic, with either congestive heart failure, angina, and/or a prior history of syncope. Predominant symptoms included dyspnea on exertion (n = 28), weakness (n = 28), orthopnea (n = 15), angina (n = 15), and presyncope with exertion (n = 7). Fourteen patients at the time of the valvuloplasty study had uncompensated congestive heart failure unresponsive to maximum medical therapy and gross interstitial pulmonary edema on chest x-ray. Twenty-seven patients had previously undergone cardiac catheterization documenting severe aortic stenosis. The cause of aortic stenosis was presumed senile degenerative calcific stenosis in 30, bicuspid calcific stenosis in two, and rheumatic in one patient. Twenty-one patients had mitral regurgitation, with scvere mitral insufficiency noted in nine; one patient had moderate mitral stenosis. Nineteen patients had significant coronary artery disease (greater than 50% luminal narrowing of at least one vessel), including six with severe three-vessel coronary artery disease (two of whom had left main involvement), one with two-vessel coronary artery disease, and 12 with one-vessel coronary artery disease. Two patients had previously undergone coronary bypass surgery. The remaining 14 had normal coronary arteries. Four patients had a previous history of myocardial infarction. Each patient was evaluated by a cardiac surgeon and was offered aortic valve replacement and an estimation of expected surgical risk. All patients subsequently refused surgical intervention. Estimation of surgical risk ranged from 2% to 50%. Major reasons for deferring surgery or for estimation of high surgical risk included advanced age (e.g., greater than 80 years of age, n = 18), severely depressed left ventricular ejection fraction (e.g., less than 40%, n = 10), the need for extensive additional surgery including coronary artery bypass grafting (n = 19) and mitral valve replacement (n = 7), documented or probable malignancy (n = 2), prior bypass surgery (n = 2), severe chronic obstructive pulmonary disease (n = 2), prior attempted aortic valve replacement (n = 1), recent untreated hip fracture (n = 1), history of severe bleeding diathesis (n = 1), morbid obesity (n = 1), and refusal to take long-term anticoagulants (n = 1). Clinical characteristics of the study group are summarized in table 1.
All patients gave informed consent for balloon aortic valvuloplasty after being informed of the risks and potential complications of the procedure according to a protocol approved by the Beth Israel Hospital Human Investigations Committee.
Aortic valvuloplasty protocol. Each patient was brought to the cardiac catheterization laboratory where a left radial cannula was placed. Twenty-three patients subsequently underwent ret- rograde left heart catheterization from a percutaneous femoral approach, and nine had retrograde brachial artery catheterization by cutdown; in one patient in whom arterial access was impossible from either the femoral or brachial approach, valvuloplasty was accomplished via a transseptal technique (see below). Right heart catheterization was performed from the femoral or brachial vein with a No. 7F balloon-tipped flotation catheter (Elecath). Left heart catheterization was performed with either a No. 7F pigtail catheter (USCI) or No. 8F Sones catheter (Cordis) and an 0.038 inch, straight-tipped guidewire to cross the aortic valve. In 13 patients, a supravalvular aortogram was obtained before crossing the aortic valve. After placement of left and right heart catheters, measurements were made of systemic arterial, left ventricular, pulmonary arterial, and pulmonary capillary wedge pressures, as well as of left ventricular and pulmonary artery oxygen saturations. Oxygen consumption was measured with a metabolic rate meter (Waters Instruments).
Cardiac output was calculated by the Fick method (02 consumption divided by arteriovenous 02 difference), and aortic valve area was determined with the Gorlin formula.5 In the Gorlin formula, antegrade flow across the aortic valve was assumed to be equal to the forward cardiac output, as calculated by the Fick method. Since antegrade flow across the valve is greater than the Fick cardiac output in the presence of aortic regurgitation, valve orifice areas were underestimated. Thus, to the extent that aortic regurgitation increased after valvuloplasty (see below), the increase in aortic orifice area was even larger than indicated by our calculations.
After prevalvuloplasty measurements were made, a 300 cm, 0.038 inch exchange guidewire was advanced through the left heart catheter into the left ventricle and the left heart catheter was removed. An additional curve had been placed in the distal tip of the exchange wire to minimize the chance of left ventricular perforation with subsequent balloon inflations and exchanges. Balloon dilatation was performed subsequently, beginning with a 12 mm valvuloplasty balloon (Meditech) in the first five patients and with use of a 15 mm balloon in the remaining 28. The initial valvuloplasty balloon catheter was advanced over the guidewire into the left ventricle, with positioning of the balloon at the aortic valve. At least three inflations were then made with hand injections of a saline/angiovist mixture. The duration of balloon inflation varied (range 10 to 60 sec), depending on each patient's systemic arterial pressure response. After balloon dilatation, a repeat measurement was made of the aortic valve gradient. If a peak-to-peak aortic gradient greater than 50 mm Hg remained, repeat dilatations were performed with a 15 mm valvuloplasty catheter, followed by an 18 mm valvuloplasty catheter, and finally by a 20 mm valvuloplasty catheter. In three patients in whom a gradient greater than 50 mm Hg remained after dilatation with a 20 mm balloon, a 23 mm balloon was also used. After balloon dilatation, the pigtail or Sones catheter was exchanged over the guidewire into the left ventricle, and repeat measurements were made of pressures and cardiac output. The left ventricular catheter was then pulled back to the central aorta, followed by a repeat supravalvular aortogram in the 13 patients who had undergone prevalvuloplasty aortography. In patients who had been catheterized by the femoral route, a No. 12F sheath (UMI) was placed in the right femoral artery at the end of the procedure. Patients catheterized via the brachial approach underwent standard suture repair of the brachial artery and closure of the skin. The right heart catheter was left in place for hemodynamic monitoring in all patients.
In one patient in whom arterial access from either the femoral 194 sensitivity slant-hole collimator that was used to obtain 30 degrees of cephalic angulation for the mLAO view. Scans were obtained with a 64 x 64 matrix for the full field of view (200 cm). Thirty-two frames per RR interval were acquired to a total of 10 million counts with an acquisition time of 5 to 8 min per view. Left ventricular global ejection fraction was determined from each mLAO scan with an operator-drawn, fixed left ventricular region of interest and a computer-generated background region of interest. A time-activity histogram was generated from the left ventricular region of interest, and end-diastolic and endsystolic frames were identified as those frames with the maximum and minimum counts, respectively. Global ejection fraction was subsequently determined from the following formula:
where EF = left ventricular ejection fraction; B = background; ED and ES = end-diastolic and end-systolic counts, respectively.
Left ventricular volume was determined by a planimetry technique in which the surface area and long axis of the left ventricle were measured with the use of the mLAO view and volume was determined according to the formula: Left ventricular peak diastolic filling rate was assessed in each patient by fitting a third-order polynomial to the rapid diastolic portion of the time-activity curve by a least squares technique and was computed in left ventricular counts per second. Values were normalized for left ventricular counts at enddiastole and expressed as end-diastolic counts per sec (EDV/ sec).
All radionuclide images were analyzed by two observers without knowledge of the hemodynamic results after valvuloplasty. Intraobserver and interobserver variability were determined for the measurement of left ventricular ejection fraction (+ 3 ejection fraction points) and left ventricular volume ( 18 ml, + 28 ml). In our laboratory, normal values for left ventricular ejection fraction are greater than 55%.
Systolic time intervals. Systolic time intervals were assessed in each patient 24 hr before and 48 hr after valvuloplasty. Carotid pulse tracings were obtained with an Irex System II M mode echocardiograph equipped with capability for phonocardiographic and pulse-tracing studies. The time to one-half carotid upstroke was measured as the time (in msec) from the initial rapid upstroke of the carotid pulse to the point at which it had attained one-half of its peak amplitude. Normal values are less than 60 msec. The left ventricular ejection time (LVET) was measured as the time (in msec) from the initial rapid upstroke of the carotid pulse to the trough of the dicrotic notch. It was subsequently corrected for heart rate according to the equation:
LVET, = LVET + 0.0016 (HR), where LVETc = rate-corrected ejection time; HR = heart rate. Normal values for ratecorrected ejection time are 0.395 + 0.013 sec for men and 0.415 + 0.011 sec for women.7
M mode echocardiography. M mode echocardiograms were obtained with an ATL Mark 600 echocardiograph 24 hr before and 48 hr after valvuloplasty. Aortic valve excursion was measured as the maximal separation between the aortic cusps in systole with use of an inner edge-to-inner edge technique. Normal values are greater than 1.6 cm. 8 Doppler echocardiography. Pulsed Doppler echocardiographic studies were performed with an ATL Mark 600 combined imaging and Doppler echocardiograph 24 hr before and 48 hr after valvuloplasty. To assess aortic insufficiency, the left ventricular outflow tract immediately below the aortic leaflets was interrogated with use of the parasternal long-axis, apical five-chamber, and parasternal short-axis views.9 To assess mitral regurgitation, the left atrium above both mitral leaflets was interrogated with use of parasternal long-axis and apical longaxis and four-chamber and two-chamber views.9 The degree of mitral regurgitation was graded as trace, mild, moderate, or severe. Trace mitral regurgitation was diagnosed if a signal of mitral regurgitation could be recorded at the leaflet level only. Mild mitral regurgitation was diagnosed if signals extended from the valve level into the first third of the left atrium. Moderate mitral regurgitation was diagnosed when signals of mitral regurgitation were obtained between one-third and two-thirds of the way toward the back wall of the left atrium, generally over at least two-thirds of its width. Severe mitral regurgitation was diagnosed when signals of mitral regurgitation could be obtained from even a wider area of the left atrium.
Criticisms concerning the use of Doppler echocardiography to grade mitral regurgitation have been raised.' In particular, the use of this technique may be limited in the presence of low cardiac output and a very large left atrium. Nevertheless, since the hemodynamic condition of the majority of patients in this study group would not allow for the safe performance of serial left ventriculography, we used the Doppler technique as our only alternative.
Statistics. Means and SDs were calculated for all variables. Paired t tests were used for determining significant differences between variables before and after valve dilatation. A p value less than .05 was considered indicative of a significant difference.
Results
Prevalvuloplasty evaluation. All 33 patients had moderately to severely thickened aortic valves, as evidenced by M mode and two-dimensional echocardiographic recordings, and all had highly echogenic areas compatible with calcification. Fluoroscopy confirmed the presence of severe aortic calcification in all patients. Mean aortic valve excursion was diminished, at 0. 21  26  20  14  19  18  28  20  17  13  24  18  14  9  25  17  47  32  34  19  22  17  25  16  23  10  19  16  19  13  37  7  13  9  20  24  17  22  24  29  26  10  17  17  41  23  23  13  11  4  12  7  19  11  14  9  13  10  19  15   19  15  16  15   48  38  27  20  25  27  41  25  26  15  45  32  24  19  31  27  65  47  48  32  32  27  45  42  33  17  23  22  30  34  47  16  27  22  33  39  32  31  50  48  39  25  24  27  45  35  31  19  30  16  27  24  29  25  21  17  20  18  30  24  30  24  33  30  22  16A  34  27A  8  7  10  9 AOSP = aortic systolic pressure; AODP = aortic diastolic pressure; AVA = calculated aortic valve area; LVSP = left ventricular systolic pressure; LVEDP = left ventricular end-diastolic pressure; PA = mean pulmonary arterial pressure; PCW = mean pulmonary capillary wedge pressure. 13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  Mean  SD   205  189  205  188  220  179  186  152  217  201  162  157  190  146  156  139  242  190  203  167  137  121  203  170  211  172  205  179  197  220  183  129  219  179  198  167  196  182  213  201  219  192  213  195  186  183  172  131  223  196  222  211  214  166  196  164  237  210  183  167  282  201  210  170  203  175A  26  25   31  27  36  24  30  27  28  20  26  20  28  26  22  12  18  16  50  36  27  19  23  17  9  7  35  18  30  28  18  17  26  9  17  13  14  14  16  23  25  29  28  16  20  20  35  25  27  15  19  10   17  11  20  12  18  12  19  16  14  19  26  25  16  15  24  19A  8  7   139  164  106  126  147  110  132  112  147  125  78  129  133  99  135  108  90  107  125  126  132  132  123  100  147  162  95  146  153  144  161  120  127  22   157  157  116  119  169  130  125  127  146  114  88  137  130  110  186  93  103  121  120  174  141  150  135   115  162  182  105  130  158  154  167  140   136A   26   62  62  73  73  47  50  42  38  50  53  60  62  54  56  45  40  73  67  60  48  53  56  52  60  72  66  66  70  69  77  65  52  57  66  54  63  61  64  63  64  61  61  65  70  42  45  55  50  60  59  59  67  46  48  49  40  60  60  66  70  59  34  40  41  57  57  9  11 196 CIRCULATION covery period to require transfusions. Eight of these patients had prevalvuloplasty hematocrits ranging between 29% and 34%.
Three patients (Nos. 3, 4, and 16; tables 1 to 5) died during the postvalvuloplasty period. One patient (90 years old, left ventricular ejection fraction 37%, prevalvuloplasty pulmonary capillary wedge pressure 37 mm Hg) died 16 hr after dilatation with unexplained hypotension and low cardiac output. A second patient (84 years old, left ventricular ejection fraction 18%, prevalvuloplasty pulmonary capillary wedge pressure 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31 inflation may be extended as long as 3 min in some patients. However, it is notable that the one patient in our series in whom arterial pressure dropped substantially during balloon dilatation had a bicuspid valve evident on echocardiographic examination; in this case, since there were only two commissures, there was presumably less blood flow around the inflated balloon. While prolonged balloon inflation may be possible in the aortic valve, it is not known at this time if longer inflation will be associated with improved valve dilatation.
Mechanism of improvement in systolic function. Among the 20 patients in our study group with a depressed left ventricular ejection fraction (i.e., less than 55%) before valvuloplasty, ejection fraction increased in 14 after dilatation, with major increases in four and mildto-moderate increases in the remaining 10. Depressed systolic function in the presence of aortic stenosis has been ascribed to both afterload mismatch and impaired contractility."-16 To date, separation of the effect of myocardial contractile dysfunction from that of afterload mismatch on pump performance has been difficult because of the lack of a load-independent index of contractile function. Theoretically, an immediate improvement in systolic function could occur with an improvement in valve orifice area and the subsequent decrease in left ventricular afterload and systolic wall stress. It may be postulated, for example, that after aortic valvuloplasty, a condition of "reversed afterload mismatch" exists in which the degree of ventricular hypertrophy is excessive in the presence of newly decreased systolic wall stress. Alternatively, there might be an increase in myocardial contractility as a result of improvement in subendocardial ischemia.
The variable systolic response of the patients in this series may in part be related to the variable causes of their depressed left ventricular ejection fractions (i.e., afterload mismatch, depressed contractility secondary to "pathological hypertrophy," and myocardial ischemia/prior infarction) and to the variable success of the balloon valvuloplasty. Moreover, it is notable that among the six patients with a baseline depressed ejection fraction in whom ejection fraction did not increase after dilatation, Doppler flow studies detected significant decreases in mitral regurgitation in four; a decrease in mitral regurgitation, which may be associated with a fall in ejection fraction, may have prevented the expected increase in ejection fraction in these four patients. Further assessment of systolic function after aortic valvuloplasty will have to await additional studies.
Complications of the study. The death of three of the study patients in the postdilatation period suggests that aortic valvuloplasty may be harmful in some patients. However, the role of valvuloplasty in the death of these patients is not clear. First, postmortem studies in these three patients showed no evidence of ballooninduced damage (i.e., torn 
